Analytic Investors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$3.58M Hold
102,931
0.04% 221
2016
Q2
$3.85M Sell
102,931
-5,379
-5% -$202K 0.05% 208
2016
Q1
$4.38M Buy
108,310
+9,612
+10% +$358K 0.05% 218
2015
Q4
$3.55M Sell
98,698
-11,897
-11% -$430K 0.04% 224
2015
Q3
$3.53M Buy
110,595
+28,984
+36% +$987K 0.05% 222
2015
Q2
$2.77M Sell
81,611
-6,276
-7% -$211K 0.04% 238
2015
Q1
$2.97M Buy
87,887
+68,339
+350% +$2.38M 0.04% 214
2014
Q4
$686K Hold
19,548
0.01% 397
2014
Q3
$640K Sell
19,548
-652
-3% -$22.2K 0.01% 429
2014
Q2
$686K Hold
20,200
0.01% 369
2014
Q1
$708K Sell
20,200
-6,381
-24% -$225K 0.01% 399
2013
Q4
$972K Buy
26,581
+12,299
+86% +$451K 0.02% 310
2013
Q3
$494K Buy
+14,282
New +$500K 0.01% 383

Other funds holding ACH

Analytic Investors's ACH Position: Q3 2016 in Review

Analytic Investors held its Accendra Health (ACH) position steady in Q3 2016 at 102,931 shares worth $3.58M. The position accounts for 0.04% of the portfolio, ranked #221.

Analytic Investors first reported a position in ACH in Q3 2013 and has held it in 13 quarters since. The position peaked at $4.38M in Q1 2016. 285 funds tracked by Wall St. Rank hold ACH as of Q3 2016.

  • Analytic Investors held 102,931 shares of Accendra Health worth $3.58M as of Q3 2016.
  • Analytic Investors left its Accendra Health share count unchanged in Q3 2016.
  • Accendra Health made up 0.04% of Analytic Investors's portfolio in Q3 2016, its #221 holding.
  • Analytic Investors first reported a position in Accendra Health in Q3 2013 and has held it in 13 quarters since.
  • Analytic Investors's Accendra Health position peaked at $4.38M in Q1 2016.
  • 285 funds tracked by Wall St. Rank held Accendra Health as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.